Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology granted inducement stock options to five new employees on July 1, 2026, under its 2023 Inducement Option Plan. The awards cover an aggregate of 68,750 shares of common stock with an exercise price of $10.78 per share, matching the closing price on the grant date.
Key figures
- New employees
- 5
- Exercise price
- 10.78
- Shares granted
- 68750
- Vesting term years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.